MIXED GUTTATE/PLAQUE PSORIASIS

Clinical trials for MIXED GUTTATE/PLAQUE PSORIASIS explained in plain language.

Never miss a new study

Get alerted when new MIXED GUTTATE/PLAQUE PSORIASIS trials appear

Sign up with your email to follow new studies for MIXED GUTTATE/PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for kids with severe skin condition

Disease control Ongoing

This study is testing a medication called certolizumab pegol in children and teenagers aged 6 to 17 who have moderate to severe plaque psoriasis. The main goals are to understand how the drug behaves in young bodies and to check its safety. It is a Phase 3 trial, which means rese…

Matched conditions: MIXED GUTTATE/PLAQUE PSORIASIS

Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

MIXED GUTTATE/PLAQUE PSORIASIS

Get alerted when new MIXED GUTTATE/PLAQUE PSORIASIS trials appear

New hope for kids with severe skin condition